All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, 110049, India
NCT Number: NCT01006811
Infantile spasms constitute a type of catastrophic epilepsy syndrome occuring in young children. The ketogenic diet has been shown to be very effective in these children. The modified Atkins diet is a less restrictive option than the ketogenic diet, which has been effective in preliminary studies on refractory epilepsy in children, adolescents and adults. Modified Atkins diet may be of special importance in infants, as proteins are not restricted, hence no problems with growth are expected. Hence this pilot study has been planned to evaluate the efficacy and tolerability of the modified Atkins diet in infantile spasms refractory to conventional treatment (ACTH, vigabatrin, and anti-epileptic drugs).
Looking for future studies?
Notify Me6 month–3 year
All sexes
Interventional
Phase 2 / Phase 3
New Delhi, National Capital Territory of Delhi, 110049, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Modified Atkins Diet administration
Other names: Dietary treatment
Modified Atkins Diet administration
Other names: Dietary treatment
Time frame: 3 months
seizure control at the end of 3 months will be classified as: spasm free; > 50% reduction in spasms; and < 50% reduction in spasms
Time frame: 3 months
All India Institute of Medical Sciences
Other
Efficacy and Tolerability of the Modified Atkins Diet in Patients With Infantile Spasms: a Pilot Study.
Acronym: ADIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06315829
Brain Diseases, Central Nervous System Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT00441896
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial DetailsNCT02954887
Brain Diseases, Central Nervous System Diseases
Little Rock, Arkansas, United States
View Trial DetailsNCT02953548
Brain Diseases, Central Nervous System Diseases
Little Rock, Arkansas, United States
View Trial Details